{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:44:36Z","timestamp":1786373076028,"version":"build-2736575974"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"abstract":"<jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Improving patient safety has become a primary objective of health systems; however, the frequency of adverse safety events continues to be unacceptable despite the attention and dedicated efforts of many stakeholders. CKD that does not require dialysis increases the risk for adverse safety events, and adverse safety events can account for a substantial portion of the poor outcomes typical of CKD. Because much of CKD care occurs outside the typical health care setting, systems designed to detect and reduce adverse safety events are not necessarily effective in this population. Underrecognition (or underappreciation) of CKD and the associated impairment of renal function contribute to the high risk for adverse safety events. Medication errors are common in CKD and account for many lapses in patient safety, but a wide range of other potentially modifiable care processes in CKD also contribute to the high rate of observed adverse safety events. This review describes the spectrum of safety concerns specific to CKD and the need for a common set of standards to improve on current general constructs and to reduce adverse safety events in this chronic disease. An accepted set of disease-specific indicators is necessary to gauge the extent of the disease-specific patient safety problem and to design means to reduce adverse safety events and improve outcomes in CKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.12781211","type":"journal-article","created":{"date-parts":[[2012,3,8]],"date-time":"2012-03-08T23:35:56Z","timestamp":1331249756000},"page":"689-695","source":"Crossref","is-referenced-by-count":4,"title":["Finding a Common Language for Patient Safety in CKD"],"prefix":"10.2215","volume":"7","author":[{"given":"Jeffrey C.","family":"Fink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie S.","family":"Joy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy L.","family":"St. Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihab M.","family":"Wahba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-24-20230811","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMsa1004404","article-title":"Temporal trends in rates of patient harm resulting from medical care.","volume":"363","author":"Landrigan","year":"2010","journal-title":"N Engl J Med"},{"key":"R5-24-20230811","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1053\/j.ajkd.2008.12.016","article-title":"Chronic kidney disease as an underrecogized threat to patient safety.","volume":"53","author":"Fink","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R6-24-20230811","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/ki.2009.353","article-title":"Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney.","volume":"76","author":"Hug","year":"2009","journal-title":"Kidney Int"},{"key":"R7-24-20230811","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2215\/CJN.00800209","article-title":"Frequency of hypoglycemia and its significance in chronic kidney disease.","volume":"4","author":"Moen","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R8-24-20230811","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archinternmed.2009.132","article-title":"The frequency of hyperkalemia and its significance in chronic kidney disease.","volume":"169","author":"Einhorn","year":"2009","journal-title":"Arch Intern Med"},{"key":"R9-24-20230811","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/pds.2128","article-title":"Life-threatening drug-associated hyperkalemia: A retrospective study from laboratory signals.","volume":"20","author":"Noize","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R10-24-20230811","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ijnurstu.2008.07.002","article-title":"Adherence to multiple, prescribed medications in diabetic kidney disease: A qualitative study of consumers\u2019 and health professionals\u2019 perspectives.","volume":"45","author":"Williams","year":"2008","journal-title":"Int J Nurs Stud"},{"key":"R11-24-20230811","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1053\/j.ajkd.2010.04.021","article-title":"Medication adherence behavior and priorities among older adults with CKD: A semistructured interview study.","volume":"56","author":"Rifkin","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R12-24-20230811","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1053\/j.ajkd.2008.03.002","article-title":"Detection and awareness of moderate to advanced CKD by primary care practitioners: A cross-sectional study from Italy.","volume":"52","author":"Minutolo","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R13-24-20230811","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1475-6773.2005.00482.x","article-title":"Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes.","volume":"41","author":"Kern","year":"2006","journal-title":"Health Serv Res"},{"key":"R14-24-20230811","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1681\/ASN.2005020192","article-title":"Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: Evidence for lack of physician awareness of chronic kidney disease.","volume":"16","author":"Stevens","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R15-24-20230811","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1001\/archinte.164.16.1788","article-title":"Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program.","volume":"164","author":"Akbari","year":"2004","journal-title":"Arch Intern Med"},{"key":"R16-24-20230811","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2369-12-1","article-title":"Effect of primary care physicians\u2019 use of estimated glomerular filtration rate on the timing of their subspecialty referral decisions.","volume":"12","author":"Greer","year":"2011","journal-title":"BMC Nephrol"},{"key":"R17-24-20230811","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s11606-008-0607-z","article-title":"Recognition and management of chronic kidney disease in an elderly ambulatory population.","volume":"23","author":"Rothberg","year":"2008","journal-title":"J Gen Intern Med"},{"key":"R19-24-20230811","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2215\/CJN.06240710","article-title":"Primary care-specialist collaboration in the care of patients with chronic kidney disease.","volume":"6","author":"Diamantidis","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R20-24-20230811","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1592\/phco.28.9.1125","article-title":"Comparison of dosing recommendations for antimicrobial drugs based on two methods for assessing kidney function: Cockcroft-Gault and Modification of Diet in Renal Disease.","volume":"28","author":"Golik","year":"2008","journal-title":"Pharmacotherapy"},{"key":"R21-24-20230811","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1345\/aph.1G635","article-title":"Comparison of the modification of diet in renal disease and Cockcroft-Gault equations for antimicrobial dosage adjustments.","volume":"40","author":"Wargo","year":"2006","journal-title":"Ann Pharmacother"},{"key":"R22-24-20230811","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.ygyno.2006.06.024","article-title":"Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies.","volume":"103","author":"de Lemos","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R23-24-20230811","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/sj.bjc.6604612","article-title":"Estimation of renal function and its potential impact on carboplatin dosing in children with cancer.","volume":"99","author":"Chinnaswamy","year":"2008","journal-title":"Br J Cancer"},{"key":"R26-24-20230811","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1592\/phco.31.11.1130","article-title":"Comparative evaluation of the Cockcroft-Gault Equation and the Modification of Diet in Renal Disease (MDRD) study equation for drug dosing: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy.","volume":"31","author":"Nyman","year":"2011","journal-title":"Pharmacotherapy"},{"key":"R27-24-20230811","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00000441-200306000-00006","article-title":"Drug-induced renal failure: Update on new medications and unique mechanisms of nephrotoxicity.","volume":"325","author":"Perazella","year":"2003","journal-title":"Am J Med Sci"},{"key":"R28-24-20230811","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2215\/CJN.02050309","article-title":"Renal vulnerability to drug toxicity.","volume":"4","author":"Perazella","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R29-24-20230811","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00041552-200203000-00005","article-title":"Recent developments in toxic nephropathy.","volume":"11","author":"Wali","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R30-24-20230811","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/intqhc\/mzg046","article-title":"Medication misuse in hospitalized patients with renal impairment.","volume":"15","author":"Salomon","year":"2003","journal-title":"Int J Qual Health Care"},{"key":"R31-24-20230811","first-page":"375","article-title":"Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : Cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.","volume":"20","author":"Stiborov\u00e1","year":"2001","journal-title":"Gen Physiol Biophys"},{"key":"R32-24-20230811","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.ajkd.2007.02.259","article-title":"Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan.","volume":"49","author":"Guh","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R33-24-20230811","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2215\/CJN.00500107","article-title":"A review of dietary supplement-induced renal dysfunction.","volume":"2","author":"Gabardi","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R34-24-20230811","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1053\/j.ajkd.2006.11.023","article-title":"Use of over-the-counter medications and natural products in patients with moderate and severe chronic renal insufficiency.","volume":"49","author":"Lalibert\u00e9","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R35-24-20230811","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ki.2009.315","article-title":"Medication errors in chronic kidney disease: One piece in the patient safety puzzle.","volume":"76","author":"Fink","year":"2009","journal-title":"Kidney Int"},{"key":"R36-24-20230811","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/pds.1962","article-title":"Analgesic use and the risk for progression of chronic kidney disease.","volume":"19","author":"Kuo","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R37-24-20230811","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.amjmed.2006.02.015","article-title":"NSAID use and progression of chronic kidney disease.","volume":"120","author":"Gooch","year":"2007","journal-title":"Am J Med"},{"key":"R38-24-20230811","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/sj.ki.4495510","article-title":"Contrast-medium-induced acute renal failure.","volume":"53","author":"Solomon","year":"1998","journal-title":"Kidney Int"},{"key":"R39-24-20230811","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/j.ajkd.2010.03.027","article-title":"Change in use of gadolinium-enhanced magnetic resonance studies in kidney disease patients after US Food and Drug Administration warnings: A cross-sectional study of Veterans Affairs Health Care System data from 2005-2008.","volume":"56","author":"Kim","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R42-24-20230811","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1681\/ASN.2009010012","article-title":"The patient-centered medical home and nephrology.","volume":"20","author":"DuBose","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R44-24-20230811","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1681\/ASN.2008030274","article-title":"Just add water.","volume":"19","author":"Negoianu","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R46-24-20230811","first-page":"S195","article-title":"syndrome.","volume":"27","author":"Guarnieri","year":"1989","journal-title":"Kidney Int"},{"key":"R47-24-20230811","doi-asserted-by":"crossref","first-page":"965","DOI":"10.7326\/0003-4819-135-11-200112040-00008","article-title":"Resistance training to counteract the catabolism of a low-protein diet in patients with chronic renal insufficiency. A randomized, controlled trial.","volume":"135","author":"Castaneda","year":"2001","journal-title":"Ann Intern Med"},{"key":"R48-24-20230811","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/j.ajkd.2007.06.006","article-title":"Balancing Fistula First with catheters last.","volume":"50","author":"Lacson","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R49-24-20230811","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1525-139X.2008.00501.x","article-title":"Has the Fistula First Breakthrough Initiative caused an increase in catheter prevalence?","volume":"21","author":"Spergel","year":"2011","journal-title":"Semin Dial"},{"key":"R50-24-20230811","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0272989X10379918","article-title":"An economic evaluation of a laboratory monitoring program for renin-angiotensin system agents.","volume":"31","author":"Smith","year":"2011","journal-title":"Med Decis Making"},{"key":"R51-24-20230811","first-page":"2680","article-title":"Nonsteroidal antiinflammatory drug toxicity monitoring and safety practices.","volume":"30","author":"Patino","year":"2003","journal-title":"J Rheumatol"},{"key":"R52-24-20230811","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/pds.1217","article-title":"Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.","volume":"16","author":"Raebel","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R53-24-20230811","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1053\/j.ajkd.2005.07.001","article-title":"Medication-related problems in ambulatory hemodialysis patients: A pooled analysis.","volume":"46","author":"Manley","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R54-24-20230811","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1053\/j.ackd.2010.06.001","article-title":"Improving medication safety in chronic kidney disease patients on dialysis through medication reconciliation.","volume":"17","author":"St Peter","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"R56-24-20230811","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2165\/00002512-199812060-00003","article-title":"Drug therapy in haemodialysis patients. Special considerations in the elderly.","volume":"12","author":"St Peter","year":"1998","journal-title":"Drugs Aging"},{"key":"R57-24-20230811","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1111\/j.1523-1755.2004.00658.x","article-title":"Analgesic prescription patterns among hemodialysis patients in the DOPPS: Potential for underprescription.","volume":"65","author":"Bailie","year":"2004","journal-title":"Kidney Int"},{"key":"R63-24-20230811","doi-asserted-by":"crossref","first-page":"ii39","DOI":"10.1136\/qhc.12.suppl_2.ii39","article-title":"Methodology and rationale for the measurement of harm with trigger tools.","volume":"12","author":"Resar","year":"2003","journal-title":"Qual Saf Health Care"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201204000-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:42:00Z","timestamp":1786369320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201204000-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.12781211","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}